Who owns ACELRX PHARMACEUTICALS INC?
- Ticker: TLPH
- CUSIP Number: 00444t209
Tip: Access positions for across all investors
Analyze quarterly positions in Acelrx Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Acelrx Pharmaceuticals stock
Who bought or sold ACELRX PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Nantahala Capital Management | 2.0M | $2.1M | 0% | Mar 2024 |
|
| Rosalind Advisors | 759k | $782k | 0% | Mar 2024 |
|
| MAI Wealth Advisors | 470k | $484k | 100% | Mar 2024 |
|
| Rock Springs Capital Management | 317k | $326k | 0% | Mar 2024 |
|
| Vanguard Group | 177k | $183k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 151k | $0 | 795589% | Mar 2024 |
|
| Geode Capital Management | 116k | $120k | -6% | Mar 2024 |
|
| Values First Advisors | 113k | $117k | -16% | Mar 2024 |
|
| BlackRock | 92k | $94k | 0% | Mar 2024 |
|
| Susquehanna International | 77k | $80k | -36% | Mar 2024 |
|
| Turtle Creek Wealth Advisors | 72k | $74k | 204% | Mar 2024 |
|
| Virtu Financial | 66k | $48k | 156% | Dec 2023 |
|
| Citadel Advisors | 41k | $43k | 37% | Mar 2024 |
|
| Jane Street | 16k | $16k | 29% | Mar 2024 |
|
| United Bank | 15k | $15k | 100% | Mar 2024 |
|
| Northern Trust | 11k | $11k | 0% | Mar 2024 |
|
| Morgan Stanley | 9.7k | $10k | -34% | Mar 2024 |
|
| Tower Research Capital | 8.1k | $8.3k | 4% | Mar 2024 |
|
| UBS Group | 2.7k | $2.8k | -77% | Mar 2024 |
|
| Group One Trading | 1.3k | $1.4k | 100% | Mar 2024 |
|
| Advisor Group Holdings | 1.3k | $1.3k | -4% | Mar 2024 |
|
| Wells Fargo & Company | 908.00 | $934.967600 | 1% | Mar 2024 |
|
| Goss Wealth Management | 500.00 | $515.000000 | 0% | Mar 2024 |
|
| Silicon Valley Capital Partners | 137.00 | $141.000400 | 0% | Mar 2024 |
|
| Global Retirement Partners | 73.00 | $75.000200 | 217% | Mar 2024 |
|
| Jpmorgan Chase & Co | 66.00 | $67.999800 | 22% | Mar 2024 |
|
| Absolute Investment Management | 50.00 | $52.000000 | 0% | Mar 2024 |
|
| FMR | 25.00 | $26.000000 | -4% | Mar 2024 |
|
| Qube Research & Technologies | 1.00 | $1.000000 | 0% | Mar 2024 |
|
Who sold out of Acelrx Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Cantor Fitzgerald, L. P. | Dec 2023 | 712k | $300M |
| Tang Capital Management | Dec 2023 | 195k | $143k |
| Millennium Management | Dec 2023 | 21k | $16k |
| Advisory Services Network | Dec 2023 | 150.00 | $109.995000 |
| Bank of America Corporation | Dec 2023 | 22.00 | $16.000600 |